Support for change control assessments and submission of post approval changes including variations and lifecycle management activities.
Change control Assessment for global market
Variation Submission for EU (Type IA, IB, Type II), Canada and ROW Market
Post approval submission to USFDA (CBE0, CBE 30, PAS, Annual report).
How We Develop and Deliver Products
at Genorra Lifescience
At Genorra Lifescience, every product goes through a structured, compliant, and quality-driven pathway. Our process ensures that each formulation meets the regulatory, safety, and performance standards of the countries we serve.